Article
01 Nov 2024
Evolving Pharmacy Landscape Signals More Stringent Regulatory Scrutiny Of "Patient Steering"
AUTHORS CONTENT
Article
04 Dec 2023
New Guidelines For Influencer Marketing #FullDisclosure
Article
01 Feb 2023
Innovative Medicines Canada Proposes Framework For Innovative Agreements For Drug Reimbursement
Article
20 Jan 2023
Marketing & Advertising Tips, Traps And Trends For 2023
Article
15 Nov 2022
In-house Counsel Primer: Managing IP And Compliance Risks In Artificial Intelligence And A Digital World
Article
28 Oct 2022
Digital Marketing & Advertising: The Legal Side Of AI, NFTs, Virtual Influencers And Dark Patterns
Article
02 Feb 2022
Competition Bureau's Interest In The Health Sector Continues
Article
02 Feb 2022
Two Health Advertising Updates – PAAB And Meta (Facebook)
Article
09 Dec 2021
Health Canada Paving The Way For More AI/ML Medical Devices
Article
04 May 2021
Transition Measures Released For Interim Order For COVID-19 Drugs
Article
05 Apr 2021
Health Canada Consultation On Electronic Media In Prescription Drug Labelling
Article
05 Apr 2021
New CADTH Report On Health Technology Trends In 2021
Article
23 Dec 2020
Health Canada – COVID-19 Update Highlights
Article
02 Dec 2020
Special Access Program And Emergency Drug Release Program Amendments In Force
Article
01 Oct 2020
New Interim Order For COVID-19 Drugs Has Wide-reaching Impact, Allowing Minister To Unilaterally Expand Indication For Non-COVID-19 Drugs
Article
30 Jul 2020
Summary Of Various COVID-19 Measures Instituted By Health Canada
Article
30 Jul 2020
Clinical Trials Relating To COVID-19
Article
10 Jun 2020
Health Canada Amends Drug Sampling Laws And Issues Guidance (effective July 1, 2020)
Article
10 Jun 2020
Canada Cracks Down On COVID-19 Related Product Advertising Claims
Article
28 May 2020
COVID-19 Developments – Federal Government Issues Request For Information For Alternative Suppliers For Certain Pharmaceuticals